Eosinophilic Asthma Treatment Nucala has FDA Approval Expanded to Children Aged 6 to 11
Source: Pixabay

Eosinophilic Asthma Treatment Nucala has FDA Approval Expanded to Children Aged 6 to 11

According to a press release from global pharmaceuticals titan GlaxoSmithKline, the US Food and Drug Administration (FDA) recently expanded approval of the Company's eosinophilic asthma treatment Nucala (generic name mepolizumab)…

Continue Reading Eosinophilic Asthma Treatment Nucala has FDA Approval Expanded to Children Aged 6 to 11
Specialty Pharmacists Play Important Role in Treatment of Primary Immunodeficiency Patients
qimono / Pixabay

Specialty Pharmacists Play Important Role in Treatment of Primary Immunodeficiency Patients

A recent publication from Specialty Pharmacy Times noted that the rapidly-growing number of available human immunoglobulin treatments for primary immunodeficiency disorders could pose challenges for specialty pharmacists when treating patients.…

Continue Reading Specialty Pharmacists Play Important Role in Treatment of Primary Immunodeficiency Patients
Michigan Researchers to Study Neurofilament Light Chain Blood Levels as a Predictor of Multiple Sclerosis
source: pixabay.com

Michigan Researchers to Study Neurofilament Light Chain Blood Levels as a Predictor of Multiple Sclerosis

According to a publication from BioSpace, researchers from Michigan's Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis are taking full advantage of recent technological advances in neurofilament light chain testing…

Continue Reading Michigan Researchers to Study Neurofilament Light Chain Blood Levels as a Predictor of Multiple Sclerosis
NHS Finally Reverses Almost 2 Year Policy Against Offering Cerliponase Alfa to Batten Disease Patients
source: pixabay.com

NHS Finally Reverses Almost 2 Year Policy Against Offering Cerliponase Alfa to Batten Disease Patients

According to a recent publication from Express Digest, England's National Health Service (NHS) has reversed its earlier position on a rare disease drug after lengthy public debate, now agreeing to…

Continue Reading NHS Finally Reverses Almost 2 Year Policy Against Offering Cerliponase Alfa to Batten Disease Patients
 A New Path to Helping Patients with Rare Diseases 
https://pixabay.com/en/hand-united-together-people-unity-1917895/

 A New Path to Helping Patients with Rare Diseases 

By: Maria Palombini, IEEE-Standards Association  For more than a decade there has been much propaganda on educating and encouraging patients to manage their healthcare. This was a direct shift in response…

Continue Reading  A New Path to Helping Patients with Rare Diseases 
Primary Sclerosing Cholangitis: This Invention Can Allow Donor Livers to Stay “Alive” Longer Before Transplant
sasint / Pixabay

Primary Sclerosing Cholangitis: This Invention Can Allow Donor Livers to Stay “Alive” Longer Before Transplant

According to a story from mirror.co.uk, a new invention called OrganOx has the potential to make liver transplants more effective and more widely available in the UK. A liver transplant…

Continue Reading Primary Sclerosing Cholangitis: This Invention Can Allow Donor Livers to Stay “Alive” Longer Before Transplant
Biogen Releases The Latest Research Results Featuring its Multiple Sclerosis Drugs
qimono / Pixabay

Biogen Releases The Latest Research Results Featuring its Multiple Sclerosis Drugs

According to a story from sectorpublishingintelligence.co.uk, studies utilizing data gathered in the real-world treatment setting are highlighting the characteristics of two different therapies for multiple sclerosis (MS) developed by the…

Continue Reading Biogen Releases The Latest Research Results Featuring its Multiple Sclerosis Drugs
FDA Approves a Program for Expanded Treatment Access in Niemann-Pick Disease Type C
rawpixel / Pixabay

FDA Approves a Program for Expanded Treatment Access in Niemann-Pick Disease Type C

According to a story from ir.stockpr.com, the biotechnology company CTD Holdings, Inc., recently announced that the US Food and Drug Administration (FDA) has issued an approval for an individual Investigational…

Continue Reading FDA Approves a Program for Expanded Treatment Access in Niemann-Pick Disease Type C